Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05116891
Title A Phase 1/2 Study of CAN04 in Combination With Different Chemotherapy Regimens in Subjects With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Cantargia AB

colorectal cancer

lung non-small cell carcinoma

bile duct cancer

Advanced Solid Tumor


Cisplatin + Gemcitabine + Nidanilimab

Docetaxel + Nidanilimab

Fluorouracil + Leucovorin + Nidanilimab + Oxaliplatin

Age Groups: adult | senior
Covered Countries FRA | ESP

No variant requirements are available.